Effects of Therapy with Amiodarone on Clinical, Functional, and Cardiac Sympathetic Innervation in Patients with Idiopathic Dilated Cardiomyopathy

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2004 Mar 31

PMID 15052240

Authors

Albert Flotats

Ignasi Carrio

Affiliations

Soon will be listed here.

References

Massie B, Fisher S, Radford M, Deedwania P, Singh B, FLETCHER R . Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation. 1996; 93(12):2128-34. DOI: 10.1161/01.cir.93.12.2128. View

Huguet F, Fagret D, Caillet M, Piriou A, Besnard J, Guilloteau D . Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study. Eur J Nucl Med. 1996; 23(5):546-9. DOI: 10.1007/BF00833390. View

Doval H, Nul D, Grancelli H, Perrone S, Bortman G, Curiel R . Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 1994; 344(8921):493-8. DOI: 10.1016/s0140-6736(94)91895-3. View

Fagret D, Wolf J, Comet M . Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct. Eur J Nucl Med. 1989; 15(9):624-8. DOI: 10.1007/BF00256942. View

Gerson M, Craft L, McGuire N, Suresh D, Abraham W, Wagoner L . Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol. 2002; 9(6):608-15. DOI: 10.1067/mnc.2002.127717. View

Singh S, FLETCHER R, Fisher S, Singh B, Lewis H, Deedwania P . Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995; 333(2):77-82. DOI: 10.1056/NEJM199507133330201. View

Somsen G, Van Vlies B, de Milliano P, Borm J, van Royen E, Endert E . Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart. 1996; 76(3):218-22. PMC: 484510. DOI: 10.1136/hrt.76.3.218. View

Gilbert E, Sandoval A, Larrabee P, Renlund D, OConnell J, Bristow M . Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart. Circulation. 1993; 88(2):472-80. DOI: 10.1161/01.cir.88.2.472. View

Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K . Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J. 1997; 133(3):353-8. DOI: 10.1016/s0002-8703(97)70232-1. View

10.

Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T . Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2003; 41(4):574-81. DOI: 10.1016/s0735-1097(02)02855-3. View

11.

Hunt S, Baker D, Chin M, Cinquegrani M, Feldman A, Francis G . ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995.... Circulation. 2001; 104(24):2996-3007. DOI: 10.1161/hc4901.102568. View

12.

Agostini D, Belin A, Amar M, Darlas Y, Hamon M, Grollier G . Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med. 2000; 41(5):845-51. View

13.

Du X, Esler M, Dart A . Sympatholytic action of intravenous amiodarone in the rat heart. Circulation. 1995; 91(2):462-70. DOI: 10.1161/01.cir.91.2.462. View

14.

Nozawa T, Igawa A, Yoshida N, Maeda M, Inoue M, Yamamura Y . Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of beta-receptors during development of hypertensive heart failure of rats. Circulation. 1998; 97(23):2359-67. DOI: 10.1161/01.cir.97.23.2359. View

15.

Merlet P, Valette H, Dubois-Rande J, Moyse D, Duboc D, Dove P . Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992; 33(4):471-7. View

16.

Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K . Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002; 105(12):1453-8. DOI: 10.1161/01.cir.0000012350.99718.ad. View

17.

Fagret D, Wolf J, Vanzetto G, Borrel E . Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med. 1993; 34(1):57-60. View

18.

Lotze U, Kaepplinger S, Kober A, Richartz B, Gottschild D, Figulla H . Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. J Nucl Med. 2001; 42(1):49-54. View

19.

Deedwania P, Singh B, Ellenbogen K, Fisher S, Fletcher R, Singh S . Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The.... Circulation. 1998; 98(23):2574-9. DOI: 10.1161/01.cir.98.23.2574. View

20.

Watanabe K, Takahashi T, Nakazawa M, Wahed M, Fuse K, Tanabe N . Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy. J Nucl Med. 2002; 43(4):531-5. View